General aspects of the secondary prevention of myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000401:mortality; D001835:Body Weight; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006322:Heart Aneurysm / Q000601:surgery; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D009203:Myocardial Infarction / Q000178:diet therapy / Q000209:etiology* / Q000534:rehabilitation; D005082:Physical Exertion; D011602:Psychophysiologic Disorders / Q000188:drug therapy / Q000209:etiology; D012306:Risk; D012907:Smoking
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants